Independent judgment for biopharma's highest-stakes decisions.
Evteev Advisory is an independent strategic advisory working with growth-stage biopharma and biotech companies, their founders, and healthcare-focused investors — on the regulatory, clinical, and capital-allocation questions that decide whether a promising program actually reaches patients.
Three questions every biopharma program eventually has to answer
Strategic Growth & Positioning
Helping founders and institutions define where a program or portfolio sits in its competitive landscape, and how to sequence growth without outrunning the evidence behind it.
Regulatory Advisory
Strategy across major global markets — FDA, EMA, PMDA in Japan, and HSA in Singapore — built around how each authority actually weighs evidence, not just its published guidance.
Portfolio Stress-Testing
Structured analysis of clinical trial failure patterns, modality risk, and therapeutic alignment — so capital gets allocated to programs that can survive Phase 3, not just reach it.
Two products, built for the people doing the work
Clinstrux
A clinical decision-support platform for pharmacists — structured workflows for medication reviews, antibiotic stewardship, deprescribing, and more, producing documentation they can save, export, or share.
Learn moreClinby
A peer community for clinical pharmacists to compare notes, ask questions, and share practical wins — built alongside Clinstrux, for the same people, on the same problems.
Learn more